This Article Full Text Full Text (PDF) All Versions of this Article: 111/18/2373    most recent 01.CIR.0000164236.19860.13v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Su, Y. R. Articles by Fazio, S. Search for Related Content PubMed PubMed Citation Articles by Su, Y. R. Articles by Fazio, S. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL Genetics Home Reference Related Collections Animal models of human disease Apoptosis Pathophysiology Gene expression Lipid and lipoprotein metabolism Mechanism of atherosclerosis/growth factors Other Vascular biology

(Circulation. 2005;111:2373-2381.)
© 2005 American Heart Association, Inc.

Vascular Medicine

Reduced ABCA1-Mediated Cholesterol Efflux and Accelerated Atherosclerosis in Apolipoprotein E–Deficient Mice Lacking Macrophage-Derived ACAT1

Yan Ru Su, MD; Dwayne E. Dove, PhD; Amy S. Major, PhD; Alyssa H. Hasty, PhD; Branden Boone, MS; MacRae F. Linton, MD; Sergio Fazio, MD, PhD

From the Atherosclerosis Research Unit, Department of Medicine, Division of Cardiovascular Medicine (Y.R.S., D.E.D., A.S.M., M.F.L., S.F.), Department of Molecular Biology and Molecular Biophisics (A.H.H.), Vanderbilt Microarray Shared Resource (B.B.), Department of Pharmacology (M.F.L.), and Department of Pathology (S.F.), Vanderbilt University Medical Center, Nashville, Tenn.

Reprint requests to Yan Ru Su, MacRae Linton, or Sergio Fazio, Vanderbilt University Medical Center, Division of Cardiovascular Medicine, 317 Preston Research Bldg, 2220 Pierce Ave, Nashville TN 37232-6300. E-mail Yan.Ru.Su{at}vanderbilt.edu, MacRae.Linton@vanderbilt.edu, or Sergio.Fazio@vanderbilt.edu

Received July 12, 2004; revision received November 18, 2004; accepted December 29, 2004.

Background— Macrophage acyl-coenzyme A:cholesterol acyltransferase 1 (ACAT1) and apolipoprotein E (apoE) have been implicated in regulating cellular cholesterol homeostasis and therefore play critical roles in foam cell formation. Deletion of either ACAT1 or apoE results in increased atherosclerosis in hyperlipidemic mice, possibly as a consequence of altered cholesterol processing. We have studied the effect of macrophage ACAT1 deletion on atherogenesis in apoE-deficient (apoE^–/–) mice with or without the restoration of macrophage apoE.

Methods and Results— We used bone marrow transplantation to generate apoE^–/– mice with macrophages of 4 genotypes: apoE^+/+/ACAT1^+/+ (wild type), apoE^+/+/ACAT1^–/– (ACAT^–/–), apoE^–/–/ACAT1^+/+ (apoE^–/–), and apoE^–/–/ACAT1^–/– (2KO). When macrophage apoE was present, plasma cholesterol levels normalized, and ACAT1 deficiency did not have significant effects on atherogenesis. However, when macrophage apoE was absent, ACAT1 deficiency increased atherosclerosis and apoptosis in the proximal aorta. Cholesterol efflux to apoA-I was significantly reduced (30% to 40%; P<0.001) in ACAT1^–/– peritoneal macrophages compared with ACAT1^+/+ controls regardless of apoE expression. 2KO macrophages had a 3- to 4-fold increase in ABCA1 message levels but decreased ABCA1 protein levels relative to ACAT1^+/+ macrophages. Microarray analyses of ACAT1^–/– macrophages showed increases in proinflammatory and procollagen genes and decreases in genes regulating membrane integrity, protein biosynthesis, and apoptosis.

Conclusions— Deficiency of macrophage ACAT1 accelerates atherosclerosis in hypercholesterolemic apoE^–/– mice but has no effect when the hypercholesterolemia is corrected by macrophage apoE expression. However, ACAT1 deletion impairs ABCA1-mediated cholesterol efflux in macrophages regardless of apoE expression. Changes in membrane stability, susceptibility to apoptosis, and inflammatory response may also be important in this process.

Key Words: acyltransferases • apolipoproteins • apoptosis • atherosclerosis • cholesterol

This article has been cited by other articles:

				H. Ait-Oufella, K. Kinugawa, J. Zoll, T. Simon, J. Boddaert, S. Heeneman, O. Blanc-Brude, V. Barateau, S. Potteaux, R. Merval, et al. Lactadherin Deficiency Leads to Apoptotic Cell Accumulation and Accelerated Atherosclerosis in Mice Circulation, April 24, 2007; 115(16): 2168 - 2177. [Abstract] [Full Text] [PDF]

				S. M. Schwartz, Z. S. Galis, M. E. Rosenfeld, and E. Falk Plaque Rupture in Humans and Mice Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 705 - 713. [Abstract] [Full Text] [PDF]

				D. M. Schrijvers, G. R.Y. De Meyer, A. G. Herman, and W. Martinet Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability Cardiovasc Res, February 1, 2007; 73(3): 470 - 480. [Abstract] [Full Text] [PDF]

				S. Fazio and M. Linton Failure of ACAT inhibition to retard atherosclerosis. N. Engl. J. Med., March 23, 2006; 354(12): 1307 - 1309. [Full Text] [PDF]

				I. Tabas Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis: The Importance of Lesion Stage and Phagocytic Efficiency Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2255 - 2264. [Abstract] [Full Text] [PDF]